We are live on ! Find out more
SKBI

SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI

Delisted

SKBI was delisted on the 18th of December, 2015.

Back to rankings

1 hedge funds and large institutions have $8K invested in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less funds holding

Funds holding: 10 → 1 (-9)

98% less capital invested

Capital invested by funds: $426K → $8K (-$418K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

Holders
1
Holders Change
-9
Holders Change %
-90%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$167K
2
SM
Sabby Management
Florida
-$141K
3
Renaissance Technologies
Renaissance Technologies
New York
-$50K
4
HighTower Advisors
HighTower Advisors
Illinois
-$22K
5
Citadel Advisors
Citadel Advisors
Florida
-$17K

SKBI Hedge Fund Activity: Q4 2015 in Review

1 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) for Q4 2015, worth a combined $8K — down 98% from $426K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SKBI and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock Institutional Trust, exiting entirely with an estimated $167K sold.

  • 1 institutional investor held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) as of Q4 2015, down from 10 in Q3 2015.
  • Funds reported $8K of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) stock for Q4 2015, down 98% quarter-over-quarter.
  • 0 funds opened new SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) positions in Q4 2015 and 9 closed out, a net change of -9 holders.
  • The largest SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) seller in Q4 2015 was BlackRock Institutional Trust, an estimated $167K sold.

Based on aggregated 13F filings for Q4 2015.